is glp-1 patented Looming drug patent expirations draw generics firms Ozempic's patent problem: how Novo

FDA, apparently, is going to continue to work with the state regulators, track the market, and also take enforcement actions that are deemed necessary so as to safeguard unsafe or fraudulent GLP-1 drugs from reaching consumers in the US.

Possible positive effects that some patients report include: Improved mood and reduced anxiety symptoms potentially linked to successful weight loss and better metabolic control [6] Enhanced self-esteem and body image as weight reduction progresses Reduced food-related anxiety and preoccupation with eating, though evidence for effects on binge eating is limited and observational Better sleep quality in some patients, though this is anecdotal and not well-established in clinical trials These improvements, when they occur, are generally considered secondary to metabolic benefits rather than direct anxiolytic effects

Specifically, there was a shortage of research regarding the relationship between GLP-1 agonists and acne

The nicotinic acetylcholine receptor 7 in subcutaneous mature adipocytes: downregulation in human obesity and modulation by diet-induced weight loss

It can slow the progression of chronic kidney disease, but kidney function should be monitored before and during use